GREM1 and sarcoma: Data from Namkoong et al [28] and Sneddon et al [29] have shown that gremlin is over-expressed in various human malignancies including carcinomas of the cervix, lung, ovary, kidney, breast, colon and pancreas as well as sarcomas.